Biomarkers of cancer stem cells

Advances in Cancer Stem Cell Biology

Volumn , Issue , 2012, Pages 45-67

  Dou, Jun ^a   Gu, Ning ^b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949178766     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-0809-3_4     Document Type: Chapter

References (151)

1. Adhikari AS, Agarwal N, Wood BM, et al. (2010). CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res 70: 4602-4612
2. Afify A, Purnell P, Nguyen L. (2009). Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Exp Mol Pathol 86: 95-100
3. Aigner S, Sthoeger ZM, Fogel M, et al. (1997). CD24, a mucin-Type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89: 3385-3395
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. (2003). Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988
5. Amitava E and Jose A C. (2010). Cancer Stem Cells: A Stride Towards Cancer Cure? J Cell Physiol 225: 7-14
6. Baba T, Convery PA, Matsumura N, et al. (2009). Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 28: 209-218
7. Bardsley MR, Horváth VJ, Asuzu DT, et al. (2010). Kitlow stem cells cause resistance to Kit/plateletderived growth factor alpha inhibitors in murine gastrointestinal stromal tumors. Gastroenterology 139: 942-952
8. Basak S, Speicher D, Eck S, et al. (1998). Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue. J Natl Cancer Inst 90: 691-697
9. Brennan SK, Wang Q, Tressler R, et al. (2010). Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms. 5 pii: e12487
10. Broadley KW, Hunn MK, Farrand KJ, et al. (2010). Side Population is not Necessary or Sufficient for a Cancer Stem Cell Phenotype in Glioblastoma Multiforme. Stem Cells 2011; 29: 452-461
11. Burkert J, Otto WR, Wright NA. (2008). Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 214: 564-573
12. Burkert J, Wright NA, Alison MR, et al. (2010). Stem cells and cancer: an intimate relationship. J Pathol 209: 287-297
13. Chao MP, Alizadeh AA, Tang C, et al. (2010). Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142: 699-713
14. Charafe-Jauffret E, Ginestier C, Iovino F, et al. (2010). Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 16: 45-55
15. Chauchereau A, Al Nakouzi N, Gaudin C, et al. (2011). Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer. Exp Cell Res 317: 262-275
16. Chen KG, Szakács G, Annereau JP, et al. (2005). Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5bet) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes. Pigment Cell Res 18: 102-112
17. Chen R, Nishimura MC, Bumbaca SM, et al. (2010). A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17: 362-375
18. Chen YC, Chang CJ, Hsu HS, et al. (2010). Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol 46: 158-65
19. Chiba T, Kita K, Zheng YW, et al. (2006). Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44: 240-251
20. Christgen M, Ballmaier M, Bruchhardt H, et al. (2007). Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Mol Cell Biochem 306: 201-212
21. Collins AT, Berry PA, Hyde C, et al. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951
22. Cox CV, Diamanti P, Evely RS, et al. (2009). Expression of CD133 on leukemia initiating cells in childhood ALL. Blood 113: 3287-3296
23. Curley MD, Therrien VA, Cummings CL, et al. (2009). CD133 expression defines a tumor initiating cell population in primaryhuman ovarian cancer. Stem Cells 12: 2875-2883
24. Dalerba P, Dylla S J, Park I K, et al. (2007). Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104: 10158-10163
25. Dean M, Fojo T, Bates S. (2005) Tumor stem cells and drug resistance. Nat Rev Cancer 5: 275-284
26. Dewan MZ, Ahmed S, Iwasaki Y, et al. (2006). Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother 60: 273-276
27. Diah SK, Smitherman PK, Aldridge J, et al. (2001). Resistance to mitoxantrone in multidrug-resistant MCF-7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. Cancer Res 61: 5461-5467
28. Ding X W, Wu JH, Jiang CP. (2010). ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sciences 86: 631-637
29. Dittfeld C, Dietrich A, Peickert S, et al. (2010). CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116. Radiother Oncol 94: 375-383
30. Dou J, Li Y, Hu W, et al. (2009). Identification of tumor stem like cells in mouse myeloma cell lines. Cell Mol Biol 55 (Suppl): OL1151-1160
31. Dou J, Pan M, Wen P, et al. (2007). Isolation and identification of cancer stem like cells from murine melanoma cell lines. Cell Mol Immunol 4: 467-472
32. Dou J, Wen P, Pan M, et al. (2009). Identification of tumor stem-like cells in mouse melanoma cell line by analysis characteristics of side population cells. Cell Bio Inter 33: 807-815
33. Elsaba TM, Martinez-PomaresL, Robins AR, et al. (2010). The Stem Cell Marker CD133 Associates with Enhanced Colony Formation and Cell Motility in Colorectal Cancer. PLoS ONE 5: e10714
34. Emmanuelle C J, Christophe G and Daniel B. (2000). Cancer stem cells: Just sign here! Cell Cycle. 229-30
35. Eramo A, Lotti F, Sette G, et al. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514
36. Fang DD, Kim YJ, Lee CN, et al. (2010). Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer 102: 1265-1275
37. Fernandez-Gonzalez R, Illa-Bochaca I, Shelton DN, et al. (2010). In situ analysis of cell populations: long-Term label-retaining cells. Methods Mol Biol 621: 1-28
38. Frank NY, Margaryan A, Huang Y, et al. (2005). ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 65: 4320-4333
39. Fredriksson R, Lagerstrom MC, Lundin LG, et al. (2003). The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63: 1256-1272
40. Furusato B, Mohamed A, Uhlén M, et al. (2010). CXCR4 and cancer. Pathol Int 60: 497-505
41. Ganaríková M., Zemanová Z., Bezinováet al. (2010). The Role of Telomeres and Telomerase Complex in Haematological Neoplasia: The Length of Telomeres as a Marker of Carcinogenesis and Prognosis of Disease. Prague Medical Report 111: 910-1105
42. Gao MQ, Choi YP, Kang S, et al. (2010). CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 29: 2672-2680
43. Ginestier C, Hur MH, Charafe-Jauffret E, et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567
44. Ginestier C, Wicinski J, Cervera N, et al. (2009). Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 8: 3297-3302
45. Goodell MA, Brose K, Paradis G, et al. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797-1806
46. Goodell MA, Brose K, Paradis G, et al. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797-1806
47. Gou S, Liu T, Wang C, et al. (2007). Establishment of clonal colonyforming assay for propagation of pancreatic cancer cells with stem cell properties. Pancreas 34: 429-435
48. Graf GA, Li WP, Gerard RD. (2002). Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 110: 659-669
49. Grichnik JM, Burch JA, Schulteis RD, et al. (2006). Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol 126: 142-153
50. Hao JL, Cozzi PJ, Khatri A, et al. (2010). CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer. Current Cancer Drug Targets 10: 287-293
51. Hao JL, Cozzi PJ, Khatri A, et al. (2010). CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer. Curr Cancer Drug Targets 10: 287-306
52. Henriksen U, Gether U, Litman T. (2005). Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2. J Cell Sci 118: 1417-1426
53. Herlyn D, Herlyn M, Steplewski Z, et al. (1979). Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol 9: 657-659
54. Hermann PC, Huber SL, Herrler T, et al. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323
55. Hirbe AC, Morgan EA, Weilbaecher KN. (2010). The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases? Curr Pharm Des 16: 1284-1290
56. Hirschmann-Jax C, Foster AE, Wulf GG, et al. (2004). A distinct side population of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101: 14228-14233
57. Ho MM, Ng AV, Lam S, Hung JY. (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827-4833
58. Hwang-Verslues WW, Kuo WH, Chang PH, et al. (2009). Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One 4: e8377
59. Ishigami S, Ueno S, Arigami T, et al. (2010). Prognostic impact of CD133 expression in gastric carcinoma. Anticancer Res 30: 2453-2457
60. Ishimoto T, Oshima H, Oshima M. (2009). CD44(+) slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E(2) in gastric tumorigenesis. Cancer Sci 101: 673-678
61. Jun D and Ning G. (2010). Emerging strategies for the identification and targeting of cancer stem cells. Tumor Biol 31: 243-253
62. Jun D, Chuilian J, Jing W, et al. (2011). Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line. Cell Biol Int 35: 227-234
63. Kasper S. (2005) Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev 4: 193-201
64. Kawasaki H, Ogura H, Arai Y, et al. (2010). Aggressive progression of breast cancer with microscopic pulmonary emboli possessing a stem cell-like phenotype independent of its origin. Pathol Int 60: 228-234
65. Kim M, Turnquist H, Jackson J. (2002). The multidrug resistance transporter ABCG2 (Breast Cancer Resistance Protein 1) Effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8: 22-28
66. Kimberly EF, Paola R, Clodia O, et al. (2009). The cancer stem cell hypothesis. In: Bagley RG and Teicher BA (eds) Cancer drug discovery and development: stem cells and cancer. 1st edn. LLC: Humana Press Publishing
67. Kimura O, Takahashi T, Ishii N, et al. (2010). Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines. Cancer Sci 101: 2145-2155
68. Klarmann GJ, Hurt EM, Mathews LA, et al. (2009). Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis 26: 433-446
69. Kondo T, Setoguchi T, Taga T. (2004). Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101: 781-786
70. Konoplev S, Rassidakis GZ, Estey E, et al. (2007). Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype. Cancer 109: 1152-1156
71. Kristiansen G, Machado E, Bretz N, et al. (2010). Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis. Lab Invest 90: 1102-1116
72. Krupkova O Jr, Loja T, Zambo I, et al. (2010). Nestin expression in human tumors and tumor cell lines. Neoplasma 57: 291-298
73. Kucerova L, Matuskova M, Hlubinova K, et al. (2010). Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 9: 129
74. Kumamoto H, Ohki K. (2010). Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors. J Oral Pathol Med 39: 87-93
75. Kusumbe AP, Mali AM, Bapat SA. (2009) CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature. Stem Cells 27: 498-508
76. Leah O, Benjamin T, Yibin K. (2009). Cancer stem cells and metastasis: emerging themes and therapeutic implications. In: Bagley RG and Teicher BA, (eds) Cancer drug discovery and development: stem cells and cancer. 1rd edn. LLC: Humana Press Publishing
77. Li C, Heidt DG, Dalerba P, et al. (2010). Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037
78. Lin PT, Gleeson JG, Corbo JC, et al. (2000). DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization. J Neurosci 20: 9152-9161
79. Lin WM, Karsten U, Goletz S, et al. (2010). Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancerinitiating cells. Virchows Arch 456: 403-409
80. Lingala S, Cui YY, Chen X, et al. (2010). Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp Mol Pathol 89: 27-35
81. Liu JJ, Shen R, Chen L, et al. (2010). Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol 3: 328-337
82. Liu T, Cheng W, Lai D Huang, et al. (2010). Characterization of primary ovarian cancer cells in different culture systems. Oncol Rep 23: 1277-1284
83. Lugli A, Iezzi G, Hostettler I, et al. (2010). Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J Cancer 103: 382-390
84. Maetzel D, Denzel S, Mack B, et al. (2009). Nuclear signalling by tumour-Associated antigen EpCAM. Nat Cell Biol 11: 162-171
85. Marhaba R, Zoller M. (2004). CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35: 211-231
86. Mark A, La B, Mina JB. (2008). Is CD133 a marker of metastatic colon cancer stem cells? J Clin Invest 118: 2021-2024
87. Matsui W, Huff CA, Wang Q, et al. (2004). Characterization of clonogenic multiple myeloma cells. Blood 103: 2332-2336
88. Matsui W, Wang Q, Barber JP, et al. (2008). Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res 68: 190-197
89. May R, Sureban SM, Lightfoot SA, et al. (2010). Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas. Am J Physiol Gastrointest Liver Physiol 299: G303-10
90. Miletti-González K E, Chen S, Muthukumaran N, et al. (2005). The CD44 receptor interacts with P Glycoprotein to promote cell migration and invasion in cancer. Cancer Res 65: 6660-6667
91. Miraglia S, GodfreyW, Yin AH, et al. (1997). A novel five-Transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90: 5013-5021
92. Mizrak D, Brittan M, Alison MR. (2008). CD133: molecule of the moment. J Pathol 214: 3-9
93. Monzani E, Facchetti F, Galmozzi E, et al. (2007). Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 43: 935-946
94. Moriyama T, Ohuchida K, Mizumoto K, et al. (2010). Enhanced cell migration and invasion of CD133+pancreatic cancer cells cocultured with pancreatic stromal cells. Cancer 116: 3357-3368
95. Mueller MT, Hermann PC, Heeschen C. (2010). Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis. Front Biosci (Elite Ed) 2: 602-613
96. Muller A, Homey B, Soto H, et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56
97. Münz M, Zeidler R, Gires O. (2005). The tumour-Associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett 225: 151-157
98. Nakanishi T, Chumsri S, Khakpour N, et al. (2010). Side-population cells in luminal-Type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling. Br J Cancer 102: 815-826
99. Nakshatri H. (2010). Radiation resistance in breast cancer: are CD44+/CD24-/proteosome low/PKH26+ cells to blame? Breast Cancer Res 12: 105
100. Natasha Y F, and Markus H F. (2009). ABCB5 gene amplification in human leukemia cells. Leuk Res 33: 1303-1305
101. Neethan A L, Yohei S, Dalong Q, et al. (2007). The Biology of Cancer Stem Cells. Annu Rev Cell Dev Biol 23: 675-699
102. O'Brien CA, Pollett A, Gallinger S, et al. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110
103. Oki Y, Younes A. (2010). Does rituximab have a place in treating classic hodgkin lymphoma? Curr Hematol Malig Rep 5: 135-139
104. Olempska M, Eisenach PA, Ammerpohl O, et al. (2007). Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepato Pancre Dis Int 6: 92-97
105. Osta WA, Chen Y, Mikhitarian K, et al. (2004). EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64: 5818-5824
106. Pannuti A, Foreman K, Rizzo P, et al. (2010). Targeting Notch to target cancer stem cells. Clin Cancer Res. 16: 3141-3152
107. Patrawala L, Calhoun T, Schneider-Broussard R, et al. (2005). Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 65: 6207-6219
108. Penumatsa K, Edassery SL, Barua A, et al. (2010). Differential expression of aldehyde dehydrogenase 1A1 (ALDH1) in normal ovary and serous ovarian tumors. J Ovarian Res 3: 28
109. Pirruccello SJ, LeBien TW. (1986). The human B cell-Associated antigen CD24 is a single chain sialoglycoprotein. J Immunol 136: 3779-3784
110. Ponta H, Sherman L, Herrlich PA. (2003). CD44: from adhesion molecules to signalling regulators. Nat Rev 4: 33-45
111. Prince ME, Sivanandan R, Kaczorowski A, et al. (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973-978
112. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. (2007). Identification and expansion of human coloncancer-initiating cells. Nature 445: 111-115
113. Rocchi E, Khodjakov A, Volk EL, et al. (2000). The product of the ABC half-Transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem Biophys Res Commun 271: 42-46
114. Saito Y, Kitamura H, Hijikata A, et al. (2010). Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med 2: 17-19
115. Salcido CD, Larochelle A, Taylor BJ, et al. (2010). Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Br J Cancer 102: 1636-1644
116. Schatton T, Murphy GF, Frank NY, et al. (2008). Identification of cells initiating human melanomas. Nature 451: 345-349
117. Schinkel AH, Jonker JW. (2003). Mammalian drug efflux transporters of the ATP binding cassette (AB) family: an overview. Advanced Drug Delivery Reviews 55: 3-29
118. Schopperle WM, Lee JM, Dewolf WC. (2010). The human cancer and stem cell marker podocalyxin interacts with the glucose-3-Transporter in malignant pluripotent stem cells. Biochem Biophys Res Commun 398: 372-376
119. Seigel GM, Campbell LM, Narayan M, et al. (2005). Gonzalez-Fernandez F. Cancer stem cell characteristics in retinoblastoma. Molecular Vision 11: 729-737
120. Sharma BK, Manglik V, Elias EG. (2010). Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease. J Surg Res 163: e11-5
121. Shay JW, Wright WE. (2010). Telomeres and telomerase in normal and cancer stem cells. FEBS Lett 584: 3819-3825
122. Shmelkov JM, Butler AT, Hooper AH, et al. (2008). CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120
123. Stephen B. K and Antonio J. (2010). More than Markers: Biological Significance of Cancer Stem Cell-Defining Molecules. Mol Cancer Ther 9: 2450-2457
124. Stuelten CH, Mertins SD, Busch JI, et al. (2010). Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel. Stem Cells 28: 649-660
125. Su C, Picard P, Rathbone MP, et al. (2010). Guanosine-induced decrease in side population of lung cancer cells: lack of correlation with ABCG2 expression. J Biol Regul Homeost Agents 24: 19-25
126. Su Y, Qiu Q, Zhang X, et al. (2010). Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev 19: 327-337
127. Suetsugu A, Nagaki M, Aoki H, et al. (2006). Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351: 820-824
128. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al. (2006). Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA 103: 11154-11159
129. Takaishi S, Okumura T, Tu S, et al. (2009). Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27: 1006-1020
130. Tomuleasa C, Soritau O, Rus-Ciuca D, et al. (2010). Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma. J Gastrointestin Liver Dis 19: 61-67
131. Turner C, Kohandel M. (2010). Investigating the link between epithelial-mesenchymal transition and the cancer stem cell phenotype: A mathematical approach. J Theor Biol 265: 329-335
132. Vega F, Davuluri Y, Cho-Vega, et al. (2010). Side population of a murine mantle cell lymphoma model contains tumor-initiating cells responsible for lymphoma maintenance and dissemination. J Cell Mol Med 14(6): 1532-1545
133. Wang J, Guo LP, Chen LZ, et al. (2007). Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 67: 3716-3724
134. Wang T, Hu HS, Feng YX, et al. (2010). Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br J Cancer 102: 1618-1626
135. Wang YH, Li F, Luo B, et al. (2009). A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasma 56: 371-378
136. Wesbuer S, Lanvers-Kaminsky C, et al. (2010). Association of telomerase activity with radio-And chemosensitivity of neuroblastomas. Radiat Oncol 5: 66
137. Wesbuer S, Lanvers-Kaminsky C, Duran-Seuberth I, et al. (2010). Association of telomerase activity with radio-And chemosensitivity of neuroblastomas. Radiat Onco 15: 66
138. Xu JX, Morii E, Liu Y, et al. (2007). High tolerance to apoptotic stimuli induced by serum depletion and ceramide in side-population cells: high expression of CD55 as a novel character for sidepopulation. Exp Cell Res 313: 1877-1885
139. Xu Y, Stamenkovic I, Yu Q. (2010). CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma. Cancer Res 70: 2455-2464
140. Yamashita T, Ji J, Budhu A, et al. (2009). EpCAM-positive hepatocellular carcinoma cells are tumorinitiating cells with stem/progenitor cell features. Gastroenterology 136: 1012-1024
141. Yang XR, Xu Y, Yu B, et al. (2010). High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 59: 953-962
142. Yao J, Cai HH, Wei JS, et al. (2010). Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells. Oncol Rep 23: 1375-1382
143. Yao J, Zhang T, Ren J, et al. (2009). Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells. Oncol Rep 22: 781-787
144. Yasuda H, Tanaka K, Saigusa S, et al. (2009). Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer. Oncol Rep 22: 709-717
145. Yeung TM, Gandhi SC, Wilding JL, et al. (2010). Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA 107: 3722-3727
146. Zen Y, Fujii T, Yoshikawa S, et al. (2007). Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. J Pathol 170: 1750-1762
147. Zhang S, Balch C, Chan MW, et al. (2008). Identification and characterization of ovarian cancerinitiating cells from primary human tumors. Cancer Res 68: 4311-4320
148. Zhang X, Jiang CL, Wang BS, et al. (2009). Primarily identification of the cell surface mark of ovarial cancer stem cells in a human ovarian cell line based on sorting side population cells. J S E U (Med Sci Edi) 28: 800-803
149. Zhou XD, Wang XY, Qu FJ. (2009). Detection of cancer stem cells from the C6 glioma cell line. J Int Med Res 37: 503-510
150. Zhu Z, Hao X, Yan M, et al. (2010). Cancer stem/progenitor cells are highly enriched in CD133(+) CD44(+) population in hepatocellular carcinoma. Int J Cancer 126: 2067-2078
151. Zlotnik A, Yoshie O. (2000) Chemokines: A new classification system and their role in immunity. Immunity 12: 121-127